ToRni27
Posted - 1 week ago
$SEOVF Hi new pumper! Welcome to Sernova! A few things the market wants to see.
1. Do a R/S 1 for 10
2. Make a CR of 250M in funding
3. Get Evotec cells into Phase 1/2
4. Please recruit 6-7 patients within 5 months. It took horrible long for second cohort B last time. And than we can talk. Do your simple homeworks first. Ty.
Dude1234
Posted - 1 week ago
$SEOVF There's no difference between 5 year cell pouch they extracted from a patient and healthy human pancreas.!!!
Dude1234
Posted - 1 week ago
$SEOVF Webcast today.
https://lifescievents.com/event/sernovacorp/
Dude1234
Posted - 2 weeks ago
$SEOVF Grabbed some shares on Saudi thing today. Small position here that added to today.
Don't like share structure and financials here, rollback more than likely, but if the Saudi's are putting some money in It, it might be worth a high risk?
GLTA.
StreetwiseReports
Posted - 2 weeks ago
Regenerative Medicine Co. Adds Saudi Arabia Diabetes Initiative: https://ow.ly/g81n50UkmKF Leading regenerative medicine company Sernova Corp. announced an agreement to explore fighting type I diabetes in Saudi Arabia. Read why one analyst believes the company's technology is "advanced." $SVA.V $SEOVF #regenmed #biotechstocks
StreetwiseReports
Posted - 1 month ago
Two Firms Aim To Create Functional Cure for Type 1 Diabetes: https://ow.ly/JBny50Ue2ST Each company is pursuing its own treatment approach to achieve insulin independence, consisting of islet cells (donor or stem cell derived), delivered into the portal vein or housed in a Cell Pouch bio-hybrid organ that is implanted in the body. Learn more about their respective programs. $VRTX $SVA.V $SEOVF #medtech Sernova Corp. Vertex Pharmaceuticals Incorporated
Nudelsuppe
Posted - 1 month ago
$SEOVF you guys still have hope or only hopium?
ToRni27
Posted - 1 month ago
$SEOVF $EVTCY Evotec Sernova‘s partner could be bought by $HALO for 2 bn us dollar. Worst case they are not interested in Sernova‘s medic device and stop spending. HALO did not promote and cut $Lipocine‘s TLANDO drug after a takeover of a small pharma cursing a melt down for Lipocine‘s stock. Lipocine found a new partner for selling TLANDO a year later.
StreetwiseReports
Posted - 1 month ago
Opportunity Arises for Co. With Cell Pouch: https://ow.ly/NxO950U5x8k This medical device owner could team up with a biotech firm that just prioritized its diabetes program, noted a Leede Financial Inc. report. $SVA.V $SEOVF #medtech #biotechstocks Sernova Corp.
Nudelsuppe
Posted - 1 month ago
$SEOVF this dead?
StreetwiseReports
Posted - 10/28/24
Regenerative Medicine Co. May Have Solution to Delivering Cell Treatments: https://ow.ly/jfm350TUKcl This Canadian life sciences firm is developing an implantable cell-containing pouch, shown in clinical trial data thus far to be safe, well-tolerated and effective. Learn why several analysts rate the company Buy. $SVA.V $SEOVF #medtech #diabetes Sernova Corp.
marvessa
Posted - 2 months ago
$SEOVF need patience, no doubt
snarkcapital
Posted - 3 months ago
Looking for a stock with huge potential (and the excitement of a rollercoaster)? $SEOVF might just be the ride for you! 🎢💸 Could it be a jackpot? Maybe! Could it burn your wallet? Also maybe! 😂 Check it out: https://open.substack.com/pub/snarkcapital/p/sernova-where-your-money-disappears
StreetwiseReports
Posted - 3 months ago
Revolutionizing Chronic Disease Treatment Through Regenerative Medicine: https://ow.ly/H31R50TpFaC A regenerative medicine therapeutics company focused on developing technologies to address chronic diseases through a regenerative approach, Sernova Corp. is focused on reforming healthcare through technology. See why experts and analysts are praising this company's potential. $SVA:TSXV $SEOVF #medtech
StreetwiseReports
Posted - 3 months ago
Co's. Cell Pouch Performs Well in Study: https://ow.ly/ohGb50ToA3C Data show Sernova Corp.'s device keeps the incorporated therapeutic cells alive and functioning for at least five years, noted a Leede Financial Inc. report. $SVA:TSXV $SEOVF #medtech #diabeties
StreetwiseReports
Posted - 3 months ago
Biotech Co. Says New Data Show Success of Type 1 Diabetes Treatment: https://ow.ly/5MKT50Tmgz3 Clinical stage biotechnology company Sernova Corp. has released new data that show success in using its Cell Pouch Transplant System to help Type 1 diabetes patients reach insulin independence. One author says the company is David taking on Goliath in the race for a cure. $SVA:TSXV $SEOVF #biotechstocks #diabetes
Anshoo
Posted - 3 months ago
$SEOVF Sernova Announces New Positive Data from Phase I/II Trial Regarding Islet Survival and Function https://finance.yahoo.com/news/sernova-announces-positive-data-phase-120000073.html?guccounter=1
StreetwiseReports
Posted - 3 months ago
Biotech Working on 'Functional Cure' for Type 1 Diabetes: https://ow.ly/vPAT50Tkmae Clinical-stage biotechnology company Sernova Corp.'s Cell Pouch implantable technology can act as a "pseudo-organ," delivering therapeutic cells to the body. Find out why one newsletter author thinks the stock could deliver a big payoff for shareholders and for patients. $SVA:TSXV $SEOVF #biotechstocks
GoodTidings
Posted - 08/30/24
$SEOVF Lets say it as it is... It was a blatant lie and he knew it!!! Pretending being commercial in 2026 while the truth is 2033 or beyond if they will ever make it to the finish line.... Not worth the risk... Too many unknowns and no cash... Early birds will get ripper here!!!!
ToRni27
Posted - 4 months ago
$SEOVF omfg panic switching CEOs lol. Evotec is in the closet as well. Congratz nice partner 👍💩
marvessa
Posted - 4 months ago
$SEOVF new CEO with great vita
butterfly_wings
Posted - 5 months ago
$SEOVF As someone who has witnessed the relentless toll of Type 1 Diabetes (T1D) on people I care about, I am compelled to draw your attention to a groundbreaking opportunity in the fight against this insidious disease. Sernova, a clinical-stage biotech company, has recently achieved a significant milestone: seven patients have become insulin-free due to their innovative therapies. 🤯 News release: https://bit.ly/3WgGdQs Despite these advancements, Sernova's stock price has been unfairly driven down to a mere $0.33 by egregious short sellers and relentless algorithmic traders. The average analyst target price stands at $3.50 per share, reflecting significant upside potential and the confidence that the financial community has in Sernova's future. The discrepancy between the current share price and true value presents a unique opportunity for investors to support a cause that transcends mere financial gain. About the tech: https://bit.ly/3zoJp3c #shortsqueeze #biotech
marvessa
Posted - 5 months ago
$SEOVF in 3 years disappeared or a few dollars worth per share
ToRni27
Posted - 6 months ago
$SEOVF no one wanted to overpay… 0.33 CAD dollar = no discount = higher or same price like stock market. What a joke of a CEO.
https://finance.yahoo.com/news/sernova-provides-public-offering-005407014.html
marvessa
Posted - 6 months ago
$SEOVF a steal
ToRni27
Posted - 04/25/24
$SEOVF please do a 20:1 RS and start from the scratch on an Evotec phase 1/2 trial. Get listed on NASDAQ after R/S and do a funding of 250M us dollar. GL
ToRni27
Posted - 04/25/24
$SEOVF Evotec is going under with this. Scammy former Evotec CEO bought this for 1.57 and 2.47 CAD right? Market manipulation at its best. Wondering if Evotec shareholders will go to court because of overpaying with their money into Sernova.
